Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1126/scitranslmed.aaf0685 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!